Relationship Between Direct Oral Anticoagulant Doses and Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation ― ANAFIE Registry Sub-Analysis ―
Circulation Journal · 2023
DOI: 10.1253/circj.cj-23-0143 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Circulation Journal, 2023. Verfasst von Masaharu Akao und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, National Hospital Organization Kyoto Medical Center. Hauptthemen laut MEDLINE: Atrial Fibrillation, Embolism, Stroke. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: This sub-analysis of the ANAFIE Registry, a prospective, observational study of >30,000 Japanese non-valvular atrial fibrillation (NVAF) patients aged ≥75 years, assessed the prevalence of direct oral anticoagulant (DOAC) under-dose prevalence, identified the factors of under-dose prescriptions, and examined the relationship between DOAC dose and clinical outcomes. METHODS AND RESULTS: Patients, divided into 5 groups by DOAC dose (standard, over-, reduced, under-, and off-label), were analyzed for background factors, cumulative incidences, and clinical outcome risk. Endpoints were stroke/systemic embolic events (SEE), major bleeding, and all-cause death during the 2-year follow-up. Of 18,497 patients taking DOACs, 20.7%, 3.8%, 51.6%, 19.6%, and 4.3%, were prescribed standard, over-, reduced, under-, and off-label doses. Factors associated with under-dose use were female sex, age ≥85 years, reduced creatinine clearance, history of major bleeding, polypharmacy, antiplatelet agents, heart failure, dementia, and no history of catheter ablation or cerebrovascular disease. After confounder adjustment, under-dose vs. standard dose was not associated with the incidence of stroke/SEE or major bleeding but was associated with a higher mortality rate. Patients receiving an off-label dose showed similar tendencies to those receiving an under-dose; that is, they showed the highest mortality rates for stroke/SEE, major bleeding, and all-cause death. CONCLUSIONS: Inappropriate low DOAC doses (under- or off-label dose) were not associated with stroke/SEE or major bleeding but were associated with all-cause death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, National Hospital Organization Kyoto Medical Center.
- Saiseikai Toyama Hospital.
- The Cardiovascular Institute.
- AOI Hachioji Hospital.
- Department of Cardiovascular Medicine, Toho University Faculty of Medicine.
- National Hospital Organization Osaka National Hospital.
Zitieren
APA
Akao, M., Inoue, H., Yamashita, T., Atarashi, H., Ikeda, T., Koretsune, Y., Okumura, K., Suzuki, S., Tsutsui, H., Toyoda, K., Hirayama, A., Yasaka, M., Yamaguchi, T., Teramukai, S., Kimura, T., Morishima, Y., Takita, A., & Shimizu, W. (2023). Relationship Between Direct Oral Anticoagulant Doses and Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation ― ANAFIE Registry Sub-Analysis ―. Circulation Journal. https://doi.org/10.1253/circj.cj-23-0143
Vancouver
Akao M, Inoue H, Yamashita T, Atarashi H, Ikeda T, Koretsune Y, et al. Relationship Between Direct Oral Anticoagulant Doses and Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation ― ANAFIE Registry Sub-Analysis ―. Circulation Journal. 2023. doi:10.1253/circj.cj-23-0143
BibTeX
@article{Akao2023,
author = {Akao, Masaharu and Inoue, Hiroshi and Yamashita, Takeshi and Atarashi, Hirotsugu and Ikeda, Takanori and Koretsune, Yukihiro and Okumura, Ken and Suzuki, Shinya and Tsutsui, Hiroyuki and Toyoda, Kazunori and Hirayama, Atsushi and Yasaka, Masahiro and Yamaguchi, Takenori and Teramukai, Satoshi and Kimura, Tetsuya and Morishima, Yoshiyuki and Takita, Atsushi and Shimizu, Wataru},
title = {Relationship Between Direct Oral Anticoagulant Doses and Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation ― ANAFIE Registry Sub-Analysis ―},
journal = {Circulation Journal},
year = {2023},
doi = {10.1253/circj.cj-23-0143}
}
EUVIMED